---
title: "Insulet Corp. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285777560.md"
description: "Insulet Corp. (PODD) shares fell 3.89% to $154.16 on Friday, underperforming against competitors despite a positive market session. The S&P 500 rose 0.84%, while Insulet's stock remains 56.56% below its 52-week high of $354.88. Competitors Eli Lilly, DexCom, and Johnson & Johnson also saw declines, with trading volume at 1.7 million, surpassing the 50-day average of 1.2 million."
datetime: "2026-05-08T21:17:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285777560.md)
  - [en](https://longbridge.com/en/news/285777560.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285777560.md)
---

# Insulet Corp. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) shed 3.89% to $154.16 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.84% to 7,398.93 and the Dow Jones Industrial Average rising 0.02% to 49,609.16.

Insulet Corp. closed 56.56% short of its 52-week high of $354.88, which the company reached on November 20th.

The stock underperformed when compared to some of its competitors Friday, as Eli Lilly & Co. (LLY) fell 2.72% to $948.45, DexCom Inc. (DXCM) fell 0.49% to $60.61, and Johnson & Johnson (JNJ) fell 0.53% to $221.32.

Trading volume (1.7 M) eclipsed its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-08-26 1717ET

### Related Stocks

- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Insulet Corp. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/287121613.md)
- [A Look At Insulet (PODD) Valuation After Strong Q1 Results And Raised Revenue Guidance](https://longbridge.com/en/news/286451912.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)